Peer genetic coaching for African American men with metastatic prostate cancer
Peer Genetic Coaches for Enhancing Genetic Testing Awareness, Navigation, and Delivery Among African American Men With Metastatic Prostate Cancer, The EXPAND Network
This study tests whether having trained peer coaches can help African American men with metastatic prostate cancer understand and access genetic testing better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Thomas Jefferson University Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT05627219 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the effectiveness of a network of peer genetic coaches in improving genetic testing awareness and access among African American men diagnosed with metastatic prostate cancer. The study involves training selected individuals as peer genetic coaches who will provide education and support to their peers regarding genetic counseling and testing. The primary focus is to address barriers such as cultural beliefs and mistrust in the healthcare system that may prevent these men from seeking necessary genetic testing. The study also aims to measure changes in knowledge and attitudes towards genetic counseling among participants.
Who should consider this trial
Good fit: Ideal candidates for this study are African American men aged 18 and older who have metastatic prostate cancer or high-risk features of prostate cancer.
Not a fit: Patients who do not identify as African American or those who do not have prostate cancer or high-risk features may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase genetic testing rates and improve health outcomes for African American men with prostate cancer.
How similar studies have performed: While peer coaching in healthcare is a growing field, this specific approach targeting genetic awareness in African American men with prostate cancer is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIM 1: Are 18 years old or older * AIM 1: Are able to read and speak English comfortably * AIM 1: Men who have experience with both prostate cancer (PCA) and genetic counseling and testing will be a priority for training, as well as men who have considerable peer education or navigation experience * AIM 2: Are 18 years old or older * AIM 2: Are African American * AIM 2: Are able to read and speak English comfortably * AIM 2: Men who meet any one of the following criteria: (1) metastatic prostate cancer; (2) prostate cancer with high-risk features (T3 or higher, Gleason 8 or higher, node positive disease); (3) with or without a diagnosis of prostate cancer with strong family history (2 or more first-degree or second-degree relatives) with prostate cancer (particularly metastatic prostate cancer or died from prostate cancer), breast cancer, ovarian cancer, pancreatic cancer, colorectal cancer, uterine cancer, renal cancer, urothelial cancer, or upper bowel cancer Exclusion Criteria: * Patients that do not meet the inclusion criteria * Children under the age of 18 * Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process
Where this trial is running
Philadelphia, Pennsylvania
- Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Amy Leader, DrPh, MPH — Thomas Jefferson University
- Study coordinator: Amy Leader, DrPh, MPH
- Email: amy.leader@jefferson.edu
- Phone: 215 955-7739
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.